Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Church & Dwight (CHD)

Church & Dwight Q3 sales up 3.8%, but $357.1 million impairment causes net loss

Mixed Impact 4 of 5 earnings Written later

Church & Dwight reported third-quarter 2024 net sales of $1,510.6 million, up 3.8%, and adjusted EPS of $0.79, up 6.8% and above its $0.67 outlook. A $357.1 million non-cash impairment on vitamin business assets produced a reported loss of $0.31 per share, and the company now expects full-year reported EPS to decline about 23%.

Key points

  • Net sales rose 3.8% to $1,510.6 million; organic sales rose 4.3%.
  • Reported loss of $0.31 per share, including a $357.1 million non-cash impairment tied to the 2012 vitamin business (VMS) acquisition.
  • Full-year outlook affirmed for net sales growth of about 3.5% and adjusted EPS growth of about 8%.
  • Adjusted gross margin expansion outlook raised to about 110 basis points; cash from operations now expected at about $1.1 billion, up from $1.08 billion.

The filing

CompanyChurch & Dwight (CHD)
Form8-K, current report
Filed with the SECNov 1, 2024, 7:02 AM ET
Accession number0000950170-24-119799

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:10 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 01, 2024.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.